Search

Search results

1. Seniors and Drug Prices in Canada and the United States, 2008 Edition

   This is the Fraser Institute's third report comparing Canada-US price differences for the prescription drugs that are most important to Canadian seniors (aged 60 and older). This year's report analyzes prices for the drugs most commonly ...

2. Canada's Drug Price Paradox, 2008

   This study regularly (since 2005) compares Canadian and American retail prices for an identical group of the 100 most commonly prescribed brand-name (mostly patented) drugs and the 100 most commonly prescribed generic drugs in Canada. In 2007, this sample ...

3. The Misguided War Against Medicines 2008

   Government spending on all types of prescription drugs (patented and non-patented) is increasing faster than any other component of health spending. And new or patented medicines tend to be more expensive compared to older drugs and other health ...

4. Access Delayed, Access Denied: Waiting for New Medicines in Canada 2008

   This is the Fraser Institute's second annual report on the amount of time patients must wait to access new medicines in Canada. The purpose of this report is: (1) to draw attention to the impact that Canadian public policies and institutions have on ...

5. Seniors and Drug Prices in Canada and the United States

   This paper compares Canada-US price differences for the drugs that were most important to Canadian seniors (aged 60 and older) in 2006. Prices are compared separately for brand name and generic prescription drugs. https://www.fraserinstitute.org/sites ...

6. Paying More, Getting Less 2007

   This is the Fraser Institute's fourth annual report on the financial sustainability of health spending by provincial governments in Canada. The report uses a moving-trend analysis to measure sustainability. The trend is derived from the average, ...

7. Cost Burden of Prescription Drug Spending in Canada and the United States, 2007 Edition

   Many drugs, generics in particular, are significantly more expensive in Canada than they are in the United States. On balance between the higher prices paid for brand name drugs and the much lower prices paid for generic drugs in the US, Americans spend ...

8. Misinformation and Wishful Thinking about Medicare's Sustainability

   In July 2007, the Canadian Medical Association Journal (CMAJ) published articles by Irfan Dhalla (2007) and François Béland (2007) denying that the growth of government health expenditures observed in Canada is unsustainable. Methodological and conceptual ...

9. Drugs not the culprit in health costs: Research shows that medicare's financial problems aren't caused by what we buy

   Appeared in the Vancouver Sun B.C. doctors have called on the province to curb spending on prescription drugs. The docs say annual spending increases are unsustainable. The Health Minister has toyed with imposing a cap on public drug budgets. But these ...

10. Canada's Drug Price Paradox, 2007

    Canadians pay much more than Americans for generic drugs because government policies in Canada distort the market for prescription medicines. In currency-equivalent terms, Canadian retail prices for generic prescription drugs in 2006 were on average 115% ...